4Abdelmouttaleb I,Danchin N,Ilardo C,et al.C-Reactive protein and coronary artery disease:additional evidence of the implication of an inflammatory process in acute coronary syndromes[J].Am Heart J,1999,137(2):346-351.
6Galis ZS,Johnson C,Godin D,et al.Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling[J].Circ Res,2002,91 (9):852-859.
7Alfon J,Pueyo Palazon C,Royo T,et al.Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit model[J].Thromb Haemost,1999,81(5):822-827.
8Joukhadar C,Klein N,Prinz M,et al.Similar effects of atorvastatin,simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia[J].Thromb Haemost,2001,85 (1):47-51.
9Tesfamariam B,Frohlich BH,Gregg RE.Differential effects of pravastatin,simvastatin and atorvastatin on Ca2+ release and vascular reactivity[J].J Cardiovasc Pharmacol,1999,34(1):95-101.
10Katznelson S.Effect of HMG-CoA reductase inhibitors on chronic allograft rejection[J].Kidney Int Suppl,1999,71:S117-S121.
2Natarajan P, Ray KK, Cannon CP. High density lipoprotein and coronary heart disease: Current and future therapies. J Am Coll Cardiol,2010,55 : 1283-1299.
3Chapman MJ, Redfern J S, McGovern ME, et al. Niacin and fi- brates in atherogenic dyslipidemia:Pharmacotherapy to reduce cardiovascular risk. Pharmacol Ther, 2010,126 : 314-345.
4Wu YF,Liu XQ,Li X,et aL USA-PRC Collaborative Study of Cardiovascular and Cardiopulmonary Epidemiology Research Group, China Multicenter Collaborative Study of Cardiovascu-- lar Epidemiology Research Group. Estimation of ten-year risk of fatal and non-fatal ischemic cardiovascular diseases in Chi- nese. Circulation, 2006,114 z 2217-2225.
5Reiner Z. Combined therapy in the treatment of dyslipidemia. Fundam Clin Pbarmacol, 2010,24 : 19-28.
6Watts GF, Karpe F. Republished review: Triglycerides and atherugenie dyslipidaemia: Extending treatment beyond sta- tins in the high-risk cardiovascular patient. Postgrad Med J, 2011,87 : 776-782.
7Baigent C,Iandray MJ,Reith C, et al. The e{feets of lowering LDL cholesterol with simvastatin plus ezetimihe in patients with chronic kidney disease (study of heart and renal protec-- tion): A randomised placebo-controlled trial. Lancet, 2011, 377:2181-2192.